Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review

International Journal of STD and AIDS

Volumn 16, Issue 8, 2005, Pages 528-537

  Revzina, Natalia V ^a   DiClemente, R J ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Papillomavirus; Prevalence; United States; Women

Indexed keywords

AFRICAN AMERICAN; DIAGNOSTIC PROCEDURE; ETHNOLOGY; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; UNITED STATES; VIRUS INFECTION; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UNITED STATES;

EID: 23944446574     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462054679214     Document Type: Review

References (23)

1. Davidson M, Schnitzer PG, Bulkow LR, et al. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994;169:792-800
2. Baken LA, Koutsky LA, Kuypers J, et al. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 1995;171:429-32
3. Shew ML, Fortenberry JD, Miles P, Amortegui AJ. Interval between menarche and first sexual intercourse, related to risk of human papillomavirus infection. J Pediatr 1994;125:661-6
4. Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas Jr JM. Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis 1995;22:23-43
5. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-41
6. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996;174:679-89
7. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8
8. Kenney JW. Ethnic differences in risk factors associated with genital human papillomavirus infections. J Adv Nurs 1996;23:1221-7
9. Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997;4:122-6
10. Kotloff KL, Wasserman SS, Russ K, et al. Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 1998;25:243-50
11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8
12. Jacobson DL, Womack SD, Peralta L, et al. Concordance of human papillomavirus in the cervix and urine among inner city adolescents. Pediatr Infect Dis J 2000;19:722-8
13. Gravitt PE, Lacey Jr JV, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001;10:95-100
14. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis 2001;183:1554-64
15. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;85:2995-3002
16. Giuliano AR, Papenfuss M, Abrahamsen M, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10: 1129-1136
17. Xi LF, Carter JJ, Galloway DA, et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 2002;11:343-51
18. Shew ML, McGlennen R, Zaidi N, Westerheim M, Ireland M, Anderson S. Oestrogen receptor transcripts associated with cervical human papillomavirus infection. Sex Transm Dis 2002;78:210-14
19. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. Infect Dis 2002;186:462-9
20. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26
21. Brown DR, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sex Transm Dis 2002;29:763-8
22. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003;95:46-52
23. Tarkowski TA, Koumans EH, Sawyer M, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis 2004;189:46-50